North America Antibody Discovery Market Forecast to 2030

At 6.8% CAGR, North America Antibody Discovery Market is Speculated to be Worth US$ 22,01,692.41 Million by 2030, says The Research Team

According toThe Research Team’ research, the North America antibody discovery market was valued at US$ 12,98,237.57 million in 2022 and is expected to reach US$ 22,01,692.41 million by 2030, registering a CAGR of 6.8% from 2022 to 2030. Developments for custom antibodies and proliferation of biotechnology industry in developing regions are among the critical factors attributed to drive the North America antibody discovery market growth.

Antibodies are indispensable research tools that enable researchers in various scientific fields to specify, identify, localize, and quantify their protein targets. Advancements in medical technologies provide support for faster and highly efficient discoveries of antibodies that are customized as per the customers’ requirements. Integrating bioinformatics in the discovery of antibodies has triggered improvements in custom antibody research. Artificial intelligence (AI) has the potential to emerge as an essential, value addition tool in the discovery of custom antibodies. AI and machine learning (ML) algorithms analyze large data sets, predict antibody-antigen interactions, and optimize antibody properties. These techniques can also aid in design, screening, and lead optimization; identify patterns; predict binding affinities; and prioritize antibody candidates for further characterization. The use of AI and ML is driven by the growing availability of big data analytics solutions and advancements in computing power, in addition to the need to efficiently analyze and interpret large-scale antibody screening data. The integration of AI and ML technologies has the potential to improve the success rates of antibody discovery projects and facilitate the development of more effective therapeutic antibodies.

The use of custom monoclonal antibodies is an attractive area in oncology research. Most of the clinical trials are performed using monoclonal antibodies derived from rabbits. For instance, anti-VEGF, a humanized anti-vascular growth endothelial factor (rabbit mAb), is currently under clinical studies for the evaluation of its effects on metastatic colorectal cancer and other solid tumors. Likewise, anti-VEGF is under clinical studies for its use in treating age-related macular degeneration. Monoclonal antibodies derived from rabbits are proven as a superior alternative to mouse-derived monoclonal antibodies due to the presence of a larger complementarity-determining region (CDR) in the antigen-binding site. In addition, monoclonal antibodies can be used to produce higher affinity clones. For instance, Creative Biolabs offers various custom polyclonal and monoclonal antibody production services, from gene expression or peptide synthesis to antibody purification and labeling. Therefore, custom monoclonal antibodies are likely to emerge as a profitable trend in the antibody discovery market during the forecast period.

On the contrary, high cost of production hampers the growth of North America antibody discovery market.

Based on antibody type, the North America antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held 81.4% market share in 2022, amassing US$ 1,056.84 billion. It is projected to garner US$ 1,832.01 billion by 2030 to register 7.1% CAGR during 2022-2030.

In terms of nature, the North America antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held 56.6% share of North America antibody discovery market in 2022, amassing US$ 734.75 billion. It is anticipated to garner US$ 1,289.28 billion by 2030 to expand at 7.3% CAGR during 2022-2030.

By services, the North America antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held 35.2% share of North America antibody discovery market in 2022, amassing US$ 457.56 billion. It is projected to garner US$ 816.06 billion by 2030 to expand at 7.5% CAGR from 2022 to 2030.

Based on end user, the North America antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held 53.3% share of North America antibody discovery market in 2022, amassing US$ 692.61 billion. It is predicted to garner US$ 1,225.24 billion by 2030 to expand at 7.4% CAGR between 2022 and 2030.

Based on country, the North America antibody discovery market is categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 84.9% share of North America antibody discovery market in 2022. It was assessed at US$ 1,102.72 billion in 2022 and is likely to hit US$ 1,903.58 billion by 2030, registering a CAGR of 7.1% during 2022-2030.

Key players operating in the North America antibody discovery market are Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Bruker Cellular Analysis Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, NanoCellect Biomedical Inc, and Biocytogen Pharmaceuticals Beijing Co Ltd, among others.

In January 2024, Biocytogen Pharmaceuticals Co Ltd launched a new sub-brand, RenBiologics, to represent the company’s antibody discovery business division. RenBiologics business will cover out-licensing/co-development of the company’s extensive library of fully human antibodies, as well as licensing of RenMice, the company’s fully human antibody/TCR discovery platforms.

In August 2023, Twist Bioscience Corp announced a drug discovery agreement with Ono Pharmaceutical Co Ltd to discover and develop novel antibodies for the treatment of autoimmune diseases.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America antibody discovery market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the North America antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America antibody discovery market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Antibody Discovery Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Investments in Research & Development
4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
4.2.1 High Cost of Production
4.3 Market Opportunities
4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:
5. Antibody Discovery Market – North America Market Analysis
5.1 North America Antibody Discovery Market Revenue (US$ Million), 2020-2030
6. North America Antibody Discovery Market Analysis – by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Antibody Discovery Market Analysis – by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Antibody Discovery Market Analysis – by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Antibody Discovery Market Analysis – by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Antibody Discovery Market – Country Analysis
10.1 North America Market Overview
10.1.1 North America: Antibody Discovery Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US
10.1.1.1.1 Overview
10.1.1.1.2 US: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 United States: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 United States: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 United States: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 United States: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Canada
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Canada: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Canada: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Canada: Antibody Discovery Market Breakdown, by End User
10.1.1.3 Mexico
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 Mexico: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 Mexico: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 Mexico: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Biolabs Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Evotec SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bruker Cellular Analysis Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BioDuro LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Sartorius AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Aragen Life Sciences Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Twist Bioscience Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NanoCellect Biomedical Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Biocytogen Pharmaceuticals Beijing Co Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Research Team
13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. United States: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 4. United States: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 5. United States: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 6. United States: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 7. Canada: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 8. Canada: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 9. Canada: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 10. Canada: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 11. Mexico: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 12. Mexico: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 13. Mexico: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 14. Mexico: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 15. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 16. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 17. Glossary of Terms, Antibody Discovery Market

LIST OF FIGURES

Figure 1. North America Antibody Discovery Market Segmentation, by Country
Figure 2. North America Antibody Discovery Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Antibody Discovery Market Revenue (US$ Million), 2020 – 2030
Figure 5. North America Antibody Discovery Market Share (%) – by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Antibody Discovery Market Share (%) – by Nature (2022 and 2030)
Figure 10. Human and Humanized: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America Antibody Discovery Market Share (%) – by Services (2022 and 2030)
Figure 14. Phage Display: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America Antibody Discovery Market Share (%) – by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Antibody Discovery Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. North America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. US: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 26. Canada: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 27. Mexico: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. Growth Strategies in the Antibody Discovery Market